References
- Dong Y, Speer C. Late-onset sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed. 2015;100(3):F257–263.
- Cortese F, Scicchitano P, Gesualdo M, et al. Early and late infections in newborns: where do we stand? A review. Pediatr Neonatol. 2016;57(4):265–273.
- Manouni El Hassani SE, Berkhout DJC, Niemarkt HJ, et al. Risk factors for late-onset sepsis in preterm infants: a multicenter case-control study. Neonatology. 2019;116(1):42–51.
- Tsai MH, Chu SM, Lee CW, et al. Recurrent late-onset sepsis in the neonatal intensive care unit: incidence, clinical characteristics, and risk factors. Clin Microbiol Infect. 2014;20(11):O928–935.
- Jung E, Lee BS. Late-onset sepsis as a risk factor for bronchopulmonary dysplasia in extremely low birth weight infants: a nationwide cohort study. Sci Rep. 2019;9(1):15448.
- Volpe J. Postnatal sepsis, necrotizing enterocolitis, and the critical role of systemic inflammation in white matter injury in premature infants. J Pediatr. 2008;153(2):160–163.
- Hofer N, Müller W, Resch B. White matter damage and neonatal sepsis. Acta Paediatr. 2011;100(7):e1–2.
- Schlapbach LJ, Aebischer M, Adams M, et al. Impact of sepsis on neuro-developmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics. 2011;128(2):e348–357.
- Lee I, Neil JJ, Huettner PC, et al. The impact of prenatal and neonatal infection on neurodevelopmental outcomes in very preterm infants. J Perinatol. 2014;34(10):741–747.
- Silveira RC, Procianoy RS, Dill JC, et al. Periventricular leukomalacia in very low birth weight neonates with high risk for neonatal sepsis. J Pediatr (Rio J). 2008;84(3):211–216.
- Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039–1051.
- Cheah IGS. Economic assessment of neonatal intensive care. Transl Pediatr. 2019;8(3):246–256.
- Qazi SA, Stoll BJ. Neonatal sepsis: a major global public health challenge. Pediatr Infect Dis J. 2009;28(1 Suppl):S1–2.
- Wojkowska-Mach J, Chmielarczyk A, Strus M, et al. Neonatal bloodstream infections in organization for economic cooperation and development countries: an update on epidemiology and prevention. J Clin Med. 2019;8(10):1750.
- Alcock G, Liley HG, Cooke L, et al. Prevention of neonatal late-onset sepsis: a randomized controlled trial. BMC Pediatr. 2017;17(1):98.
- Hayes R, Hartnett J, Semova G, et al. Neonatal sepsis definitions from randomised clinical trials. Pediatr Res. 2021 Nov 6. DOI:10.1038/s41390-021-01749-3.
- Amaral LM, Wallace K, Owens M, et al. Pathophysiology, and current clinical management of preeclampsia. Curr Hypertens Rep. 2017;19(8):61.
- Crowther CA, Middleton PF, Voysey M, et al. Assessing the neuroprotective benefits for babies of antenatal magnesium sulfate: an individual participant data meta-analysis. PLoS Med. 2017;14(10):e1002398.
- Doyle LW, Crowther CA, Middleton P, et al. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review. Obstet Gynecol. 2009;113(6):1327–1333.
- Velissaris D, Karamouzos V, Pierrakos C, et al. Hypomagnesemia in critically ill sepsis patients. J Clin Med Res. 2015;7(12):911–918.
- Seyama T, Kamei Y, Iriyama T, et al. Pretreatment with magnesium sulfate attenuates white matter damage by preventing cell death of developing oligodendrocytes. J Obstet Gynaecol Res. 2018;44(4):601–607.
- Sugimoto J, Romani AM, Valentin-Torres AM, et al. Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. J Immunol. 2012;188(12):6338–6346.
- Pietrasanta C, Pugni L, Ronchi A, et al. Vascular endothelium in neonatal sepsis: basic mechanisms and translational opportunities. Front Pediatr. 2019;7:340.
- Shepherd E, Salam RA, Manhas D, et al. Antenatal magnesium sulphate and adverse neonatal outcomes: a systematic review and meta-analysis. PLoS Med. 2019;16(12):e1002988.
- Wolf HT, Brok J, Henriksen TB, et al. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial. Bjog. 2020;127(10):1217–1225.
- Garfinkle J, Yoon EW, Alvaro R, et al. Trends in sex-specific differences in outcomes in extreme preterms: progress or natural barriers? Arch Dis Child Fetal Neonatal Ed. 2020;105(2):158–163.
- Nguyen TN, Crowther CA, Wilkinson D, et al. Magnesium sulphate for women at term for neuroprotection of the fetus. Cochrane Database Syst Rev. 2013;28(2):CD009395.
- Brook B, Amenyogbe N, Ben-Othman R, et al. A Controlled Mouse Model for Neonatal Polymicrobial Sepsis. J Vis Exp. 2019;27(143). DOI:10.3791/58574